Drug-drug interactions in oncology - prevalence and clinical relevance

被引：0
|
作者：
Hinnerkort, A. [1 ,2 ]
Liekweg, A. [1 ]
Muellerleile, U. [3 ]
Tiede, S. [3 ]
Bruellke, N. [3 ]
Jaehde, U. [2 ]
机构：
[1] Asklepios Kliniken Hamburg GmbH, Dept Pharm, Hamburg, Germany
[2] Univ Bonn, Dept Clin Pharm, Inst Pharm, D-5300 Bonn, Germany
[3] Asklepios Klin Barmbek, Dept Oncol & Pallit Med, Hamburg, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [1] CLINICAL RELEVANCE OF DRUG-DRUG INTERACTIONS WITH DAROLUTAMIDE
    Floyd, Rebecca
    Sutton, Jennifer
    Olivier, Kara
    Zurth, Christian
    Smith, Matthew R.
    Shore, Neal
    ONCOLOGY NURSING FORUM, 2020, 47 (02)
  • [2] Prevalence of potential drug-drug interactions requiring biomarkers for the assessment of clinical relevance
    Geerts, Arjen
    de Koning, Fred H. P.
    de Smet, Peter A. G.
    van Solinge, Wouter W.
    Egberts, Toine C. G.
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 251 - 252
  • [3] THE CLINICAL RELEVANCE OF DRUG-DRUG AND DRUG-HERBAL INTERACTIONS
    Schwab, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 1 - 1
  • [4] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Lauren A. Marcath
    Taylor D. Coe
    Emily K. Hoylman
    Bruce G. Redman
    Daniel L. Hertz
    BMC Cancer, 18
  • [5] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Marcath, Lauren A.
    Coe, Taylor D.
    Hoylman, Emily K.
    Redman, Bruce G.
    Hertz, Daniel L.
    BMC CANCER, 2018, 18
  • [6] Mechanisms and the clinical relevance of complex drug-drug interactions
    Roberts, Arthur G.
    Gibbs, Morgan E.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2018, 10 : 123 - 134
  • [7] Drug-Drug Interactions of FXI Inhibitors: Clinical Relevance
    Ferri, Nicola
    Colombo, Elisa
    Corsini, Alberto
    HEMATOLOGY REPORTS, 2024, 16 (01) : 151 - 163
  • [8] Drug-drug interactions in a geriatric outpatient cohort - Prevalence and relevance
    Tulner, Linda R.
    Frankfort, Suzanne V.
    Gijsen, George J. P. T.
    van Campen, Jos P. C. M.
    Koks, Cornelis H. W.
    Beijnen, Jos H.
    DRUGS & AGING, 2008, 25 (04) : 343 - 355
  • [9] Antidepressant drug-drug interactions: Clinical relevance and risk management
    Nemeroff, Charles B.
    Preskorn, Sheldon H.
    DeVane, C. Lindsay
    CNS SPECTRUMS, 2007, 12 (05) : 4 - +
  • [10] Clinical relevance of drug-drug interactions - A structured assessment procedure
    van Roon, EN
    Flikweert, S
    le Comte, M
    Langendijk, PNJ
    Kwee-Zuiderwijk, WJM
    Smits, P
    Brouwers, JRBJ
    DRUG SAFETY, 2005, 28 (12) : 1131 - 1139
12345